A61K 51/1224
Lipoprotein vesicles
Official title: {Lipoprotein vesicles, e.g. HDL and LDL proteins}
A61K51/1224 (Lipoprotein vesicles) appears on 14 US grants and 18 published applications in this corpus.
Search patents in A61K- Granted patents
- 14
- Published applications
- 18
- Assignees
- 11
- Inventors
- 29
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis5 Aug 2025US 12,377,054 B2Icahn School of Medicine at Mount Sinai
- Reconstituted HDL nanoparticles for delivery of radioactive agents and uses thereof28 Jan 2025US 12,208,146 B2The Autonomous University of the State of Mexico
- Spherical rHDLs for targeted imaging16 Jul 2024US 12,036,294 B2Signablok, Inc.
- Methods and compositions for targeted delivery24 Aug 2021US 11,097,020 B2Signablok, Inc.
- Methods and compositions for targeted imaging19 Jan 2021US 10,894,098 B2Signablok, Inc.
- Methods and materials for treating cancer8 Oct 2026US 2026/0306684 A1Mayo Foundation for Medical Education and Research
- Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis6 Aug 2026US 2026/0224505 A1Icahn School of Medicine at Mount Sinai
- Methods for inhibiting trained immunity with nanobiologic compositions3 Jul 2025US 2025/0213665 A1Icahn School of Medicine at Mount Sinai
- Methods for targeted imaging with spherical rhdls19 Sep 2024US 2024/0307565 A1Signablok, Inc.
- Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis13 Jul 2023US 2023/0218537 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Method and means for detection of arterial lesions61US 4,660,563 AMassachusetts Institute of Technology · 1987
- Radiolabelled lipoproteins and method for making same27US 4,647,445 AMassachusetts Institute of Technology · 1987
- Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis17US 7,255,850 B2The Regents of the University of California · 2007
- Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis15US 8,021,644 B2The Regents of the University of California · 2011
- Method and means for detection of adrenal metabolic activity8US 4,937,067 AMassachusetts Institute of Technology · 1990